Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| European Georges Pompidou Hospital | OTHER |
| Centre Chirurgical Marie Lannelongue | OTHER |
| Clinique Pasteur Toulouse | OTHER |
Not provided
Not provided
Not provided
Not provided
Arrhythmias represent one of the main late complications in patients with congenital heart disease. Atrial arrhythmias are associated with a significant morbidity and are the first cause of urgent hospitalization, and sudden death from ventricular arrhythmias is a leading cause of death in this population.
The exponential increase of the number of patients with congenital heart disease and the improvement of ablative technologies are associated with a significant increase of the number of catheter ablation procedures.
Most of available studies are retrospective or include a limited number of patients.
The aim of this study is to assess the efficacy of catheter ablation in patients with congenital heart disease through a national prospective registry. Secondary objectives are i) to identify factors associated with catheter ablation efficacy in different cardiac defects, ii) to describe complications associated with catheter ablation in this specific population, and iii) to assess the impact of catheter ablation on quality of life of patients with congenital heart disease.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Catheter ablation | Procedure | Catheter ablation of arrhythmia |
| Measure | Description | Time Frame |
|---|---|---|
| Recurrence of targeted arrhythmia | Rate of freedom from targeted arrhythmia recurrence | 12 months |
| Measure | Description | Time Frame |
|---|---|---|
| Recurrence of any arrhythmia | Rate of freedom from any arrhythmia recurrence at 12 months | 12 months |
| Long-term recurrence of targeted and any arrhythmia | Rate of freedom from targeted and any arrhythmia recurrence |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
All patients with congenital heart disease referred for catheter ablation
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Victor Waldmann, MD, MPH | Contact | +33676098007 | victor.waldmann@gmail.com |
| Name | Affiliation | Role |
|---|---|---|
| Victor Waldmann, MD, MPH | Paris Cardiovascular Research Center (Inserm U970) | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Georges Pompidou European Hospital | Recruiting | Paris | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D006330 | Heart Defects, Congenital |
| D001145 | Arrhythmias, Cardiac |
| ID | Term |
|---|---|
| D018376 | Cardiovascular Abnormalities |
| D002318 | Cardiovascular Diseases |
| D006331 | Heart Diseases |
| D000013 | Congenital Abnormalities |
Not provided
Not provided
| ID | Term |
|---|---|
| D017115 | Catheter Ablation |
| ID | Term |
|---|---|
| D000078703 | Radiofrequency Ablation |
| D000078702 | Radiofrequency Therapy |
| D013812 | Therapeutics |
| D055011 | Ablation Techniques |
Not provided
Not provided
Not provided
Not provided
Not provided
| 24 months |
| Complications | Complications associated with catheter ablation | 1 month |
| Quality of life assessed by SF36 score | Quality of life change before and after catheter ablation assessed by SF36 score | 6 months |
| Quality of life assessed by EQ5D3L score | Quality of life change before and after catheter ablation assessed by EQ5D3L score | 6 months |
| D009358 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D013514 |
| Surgical Procedures, Operative |